A Clinical Trial With a Self-controlled, Multicenter, Pediatric EEG Intelligent Analysis System to Assist in Diagnosis
1 other identifier
observational
1,000
0 countries
N/A
Brief Summary
A diagnostic accuracy study on Artificial intelligence EEG analysis system assisted doctors to diagnose pediatric epilepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2025
CompletedFirst Posted
Study publicly available on registry
April 9, 2025
CompletedStudy Start
First participant enrolled
June 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
April 9, 2025
March 1, 2025
12 months
March 27, 2025
April 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the coincidence rate between doctors' independent diagnosis and the diagnosis recommended by the AI system.
The reference standard is the EGG interpreted by 3 clinicians who had attended the uniformly training program and had more than 5 years of experience in diagnosing epilepsy in children.
Within 48 hours after the completion of EEG monitoring
Secondary Outcomes (1)
To evaluate the diagnostic efficiency of clinicians at two-stage
Immediately after the end of EEG interpretation
Interventions
The first stage, physicians independently diagnose pediatric epilepsy with EEG; the second stage, Artificial intelligence EEG analysis system assisted physicians to diagnose pediatric epilepsy
Eligibility Criteria
children aged \< 18 years old with suspected epilepsy who need EEG examination
You may qualify if:
- Age \< 18 years old
- Children with suspected epilepsy
You may not qualify if:
- During EEG monitoring, the patients had other serious neurological diseases and mental diseases concurrently
- Used medication that affect EEG data within 3 weeks, such as sedatives and anti-epileptic medications
- Substandard data quality, such as data lack of key records, electrode connection discontinuity, insufficient recording time, or the presence of serious artifacts
- Incomplete or missing data
- Equipment or operational abnormalities, data for which EEG monitoring has not been performed continuously
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 27, 2025
First Posted
April 9, 2025
Study Start
June 3, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
April 9, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share